Cargando…

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy

BACKGROUND: To characterize healthcare resource utilization and costs in patients with metastatic lung cancer receiving chemotherapy in the US. METHODS: Using data from a large private multi-payer health insurance claims database (2000-2006), we identified all patients beginning chemotherapy for met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vera-Llonch, Montserrat, Weycker, Derek, Glass, Andrew, Gao, Sue, Borker, Rohit, Barber, Beth, Oster, Gerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239411/ https://www.ncbi.nlm.nih.gov/pubmed/22074001 http://dx.doi.org/10.1186/1472-6963-11-305

Ejemplares similares

Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011)

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
por: Vera-Llonch, Montserrat, et al.
Publicado: (2009)

Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
por: Amdahl, Jordan, et al.
Publicado: (2020)

Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
por: Weycker, Derek, et al.
Publicado: (2014)

US healthcare costs attributable to type A and type B influenza
por: Yan, Songkai, et al.
Publicado: (2017)

FRI090 Patterns Of Triglyceride Testing And Results Over Time Among Patients With Diabetes And Severe Hypertriglyceridemia In US Clinical Practice
por: Kutrieb, Emily, et al.
Publicado: (2023)

Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
por: Averin, Ahuva, et al.
Publicado: (2020)

Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
por: Weycker, Derek, et al.
Publicado: (2015)

Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
por: Weycker, Derek, et al.
Publicado: (2013)

Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice
por: Weycker, Derek, et al.
Publicado: (2012)

Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules
por: Edelsberg, John, et al.
Publicado: (2018)

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Attributable Cost of Adult Hospitalized Pneumonia Beyond the Acute Phase
por: Weycker, Derek, et al.
Publicado: (2020)

Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis
por: Solem, Caitlyn T., et al.
Publicado: (2016)

Hospitalizations for osteoporosis-related fractures: Economic costs and clinical outcomes
por: Weycker, Derek, et al.
Publicado: (2016)

Characteristics and healthcare costs of patients with fibromyalgia syndrome
por: Berger, A, et al.
Publicado: (2007)

Cost-Effectiveness of Adult Universal Hepatitis B Vaccination
por: Oster, Gerry, et al.
Publicado: (2022)

Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2011)

Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Sugemalimab plus chemotherapy vs. chemotherapy for metastatic non-small-cell lung cancer: A cost-effectiveness analysis
por: Liang, Xueyan, et al.
Publicado: (2023)

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
por: Weycker, Derek, et al.
Publicado: (2019)

Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
por: Kim, Sungjin, et al.
Publicado: (2020)

Comorbid Conditions in Patients With Metastatic Colorectal Cancer
por: Fu, Alex Z, et al.
Publicado: (2011)

Systematic Review on Infusion Reactions Associated with Chemotherapies and Monoclonal Antibodies for Metastatic Colorectal Cancer
por: Song, Xue, et al.
Publicado: (2011)

Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network
por: Chen, Clara, et al.
Publicado: (2014)

Disease Burden and Treatment Patterns Associated With Eosinophilic Esophagitis in the United States: A Retrospective Claims Study
por: Lu, Mei, et al.
Publicado: (2022)

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis
por: Ma, Qiufei, et al.
Publicado: (2016)

Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)
por: Ligibel, Jennifer A, et al.
Publicado: (2021)

Resource Use and Costs Associated to the Initial Phase of Treatment for Patients with Colorectal Cancer Receiving Post-Surgery Chemotherapy: A Cost Analysis from a Healthcare Perspective
por: Nejati, Mina, et al.
Publicado: (2021)

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
por: Hale, J P, et al.
Publicado: (2002)

Candida albicans endocarditis in a child with acute lymphoblastic leukemia: A dreaded complication of intensive chemotherapy
por: Chaudhary, Narendra, et al.
Publicado: (2013)

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
por: Atwood, Mark, et al.
Publicado: (2018)

Major Surgery in Patients with Metastatic Colorectal Cancer in Western Europe
por: Zhao, Zhongyun, et al.
Publicado: (2011)

The Cost-Effectiveness of Tislelizumab Plus Chemotherapy for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer
por: Luo, Xia, et al.
Publicado: (2022)

Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
por: Hue, Jonathan J., et al.
Publicado: (2021)

Weight Changes in Women Receiving Chemotherapy for Non-Metastatic Breast Cancer in Saudi Arabia
por: Al-Hajeili, Marwan, et al.
Publicado: (2021)

Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions
por: Weycker, Derek, et al.
Publicado: (2016)

Resource utilization and costs before and after total joint arthroplasty
por: Bozic, Kevin J, et al.
Publicado: (2012)

Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism
por: Martin, Susan, et al.
Publicado: (2019)

Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
por: Yarlas, Aaron, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_va2n2e7pjfi9shgsthrtv9frg1